Skip to Main Content

Author Details

Robin A Pollini
West Virginia University, School of Public Health
2005
71
28
PMIDPaper TitleJournal TitlePublished Year
36940779Drug treatment perspectives and experiences among family and friends of people who use illicit opioids: A mixed methods study.J Subst Use Addict Treat2023
37149144Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility.J Am Pharm Assoc (2003)2023
36870937"You didn't have a choice, but to be on your train. The train was moving": West Virginia pharmacists' perspectives on opioid dispensing during the evolution of the opioid crisis.J Am Pharm Assoc (2003)2023
36940779Drug treatment perspectives and experiences among family and friends of people who use illicit opioids: A mixed methods study.J Subst Use Addict Treat2023
37244144Civil commitment perspectives and experiences among friends and family of people who use illicit opioids in Massachusetts, USA.Int J Drug Policy2023
37149144Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility.J Am Pharm Assoc (2003)2023
37244144Civil commitment perspectives and experiences among friends and family of people who use illicit opioids in Massachusetts, USA.Int J Drug Policy2023
36870937"You didn't have a choice, but to be on your train. The train was moving": West Virginia pharmacists' perspectives on opioid dispensing during the evolution of the opioid crisis.J Am Pharm Assoc (2003)2023
34511372Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.J Am Pharm Assoc (2003)2022
35450833Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.J Am Pharm Assoc (2003)2022
35418048If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.BMC Public Health2022
35357738Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.J Viral Hepat2022
36257694Pain Management During West Virginia's Opioid Crisis.J Am Board Fam Med2022
36414361Mixed methods research: A primer for the vascular surgeon.Semin Vasc Surg2022
34469034A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.Health Soc Care Community2022
34864356Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts.Drug Alcohol Depend2022
34511372Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.J Am Pharm Assoc (2003)2022
35272687"The DEA would come in and destroy you": a qualitative study of fear and unintended consequences among opioid prescribers in WV.Subst Abuse Treat Prev Policy2022
34491889Mobile phone and internet use among people who inject drugs: Implications for mobile health interventions.Subst Abus2022
34998246Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.Drug Alcohol Depend2022
35450833Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.J Am Pharm Assoc (2003)2022
35418048If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.BMC Public Health2022
35357738Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.J Viral Hepat2022
36414361Mixed methods research: A primer for the vascular surgeon.Semin Vasc Surg2022
36257694Pain Management During West Virginia's Opioid Crisis.J Am Board Fam Med2022
35272687"The DEA would come in and destroy you": a qualitative study of fear and unintended consequences among opioid prescribers in WV.Subst Abuse Treat Prev Policy2022
34998246Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.Drug Alcohol Depend2022
34864356Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts.Drug Alcohol Depend2022
34469034A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.Health Soc Care Community2022
34491889Mobile phone and internet use among people who inject drugs: Implications for mobile health interventions.Subst Abus2022
32415706'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state.Addiction2021
32415706'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state.Addiction2021
33530734Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction.Psychiatr Serv2021
33526045Assessing the impact of a restrictive opioid prescribing law in West Virginia.Subst Abuse Treat Prev Policy2021
33765516A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia.Int J Drug Policy2021
34305698Using Positive Empathy Interventions to Reduce Stigma Toward People Who Inject Drugs.Front Psychol2021
33129133Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley.Int J Drug Policy2021
33284083System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.Subst Abus2021
34379030Consider the Source: Associations between Syringe Sources and Risky Injection Behaviors in California's Central Valley.Subst Use Misuse2021
33765516A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia.Int J Drug Policy2021
33530734Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction.Psychiatr Serv2021
33526045Assessing the impact of a restrictive opioid prescribing law in West Virginia.Subst Abuse Treat Prev Policy2021
34379030Consider the Source: Associations between Syringe Sources and Risky Injection Behaviors in California's Central Valley.Subst Use Misuse2021
34305698Using Positive Empathy Interventions to Reduce Stigma Toward People Who Inject Drugs.Front Psychol2021
33284083System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.Subst Abus2021
33129133Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley.Int J Drug Policy2021
32651116Assessing pharmacy-based naloxone access using an innovative purchase trial methodology.J Am Pharm Assoc (2003)2020
31775079Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.Int J Drug Policy2020
32651116Assessing pharmacy-based naloxone access using an innovative purchase trial methodology.J Am Pharm Assoc (2003)2020
31775079Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.Int J Drug Policy2020
  • 1 - 50 of 142

Recommended Authors

Chelsea L Shover
Division of General Internal Medicine and Health Services Research.
Career Start Year 2017
Number of shared co-authors 1
Tiffany Champagne-Langabeer
The University of Texas Health Science Center at Houston (UTHealth Houston)
Career Start Year 2015
Number of shared co-authors 0
David Goodman-Meza
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 6
Sarah P Hiller
University of California
Career Start Year 2011
Number of shared co-authors 2
Benjamin D Tyndall
Career Start Year 2011
Number of shared co-authors 0
Katherine R Schafer
Wake Forest School of Medicine, University of North Carolina
Career Start Year 2010
Number of shared co-authors 0
Lauren K Whiteside
University of Washington, Harborview Medical Center
Career Start Year 2009
Number of shared co-authors 0
Leah Harvey
Dublin City University
Career Start Year 2009
Number of shared co-authors 0
Tim K Mackey
University of California San Diego
Career Start Year 2009
Number of shared co-authors 2
Tommi L Gaines
University of California San Diego
Career Start Year 2007
Number of shared co-authors 3
Brooke E Hoots
Centers for Disease Control and Prevention
Career Start Year 2007
Number of shared co-authors 0
Erin L Winstanley
Rockefeller Neuroscience Institute, West Virginia University
Career Start Year 2006
Number of shared co-authors 0
Elizabeth Needham Waddell
Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 0
Maya Vijayaraghavan
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
Jacob J van den Berg
Tufts University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Emily C Williams
University of Washington
Career Start Year 2005
Number of shared co-authors 0
Erin P Ricketts
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 2
Aleksandar Kecojevic
William Paterson University
Career Start Year 2004
Number of shared co-authors 0
Amanda M Midboe
Center for Innovation to Implementation, VA Palo Alto Healthcare System
Career Start Year 2004
Number of shared co-authors 0
Stacy A Sterling
Kaiser Permanente Northern California
Career Start Year 2003
Number of shared co-authors 0
Amy Nunn
Brown University
Career Start Year 2003
Number of shared co-authors 0
Helena Hansen
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 4
Adam J Gordon
Clinical Care, University of Utah School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Derek D Satre
University of California San Francisco, Kaiser Permanente Northern California
Career Start Year 2001
Number of shared co-authors 0
Harold A Pollack
The University of Chicago
Career Start Year 1999
Number of shared co-authors 0
Beth A Reboussin
Wake Forest School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Aaron M Gilson
University of Wisconsin-Madison School of Pharmacy.
Career Start Year 1994
Number of shared co-authors 0
David A Fiellin
Yale School of Public Health, United States Yale School of Medicine
Career Start Year 1991
Number of shared co-authors 0
Steven Shoptaw
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 2
Richard A Rawson
David Geffen School of Medicine, University of California los angeles
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Jennifer L Syvertsen
University of California riverside
Co-authored papers 9
Kimberly C Brouwer
University of California
Co-authored papers 6
Daniel E Ford
Johns Hopkins University School of Medicine
Co-authored papers 5
Richard S Garfein
University of California San Diego
Co-authored papers 3
Leo Beletsky
Northeastern University School of Law, Bouve College of Health Sciences
Co-authored papers 3
Victoria D Ojeda
University of California, San Diego Herbert Wertheim School of Public Health
Co-authored papers 3
Estela Blanco
Co-authored papers 1
Joseph Friedman
Center for Social Medicine and Humanities, University of California
Co-authored papers 1
Simon D W Frost
Co-authored papers 1
Alex A T Bui
Co-authored papers 1
Minya Pu
University of California
Co-authored papers 1
Alex A T Bui
University of California Los Angeles
Co-authored papers 1
Maryam Khodaverdi
West Virginia Clinical and Translational Sciences Institute
Co-authored papers 1
Philippe Bourgois
Center for Social Medicine, university of california los angeles
Co-authored papers 1
Release 1.2